Fidelity Biopharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for FIDELITY BIOPHARMA
FIDELITY BIOPHARMA has one approved drug.
There are two US patents protecting FIDELITY BIOPHARMA drugs.
Summary for Fidelity Biopharma
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Fidelity Biopharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Biopharma | ONTRALFY | tizanidine hydrochloride | SOLUTION;ORAL | 216190-001 | Dec 12, 2024 | RX | Yes | Yes | 12,042,484 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Fidelity Biopharma | ONTRALFY | tizanidine hydrochloride | SOLUTION;ORAL | 216190-001 | Dec 12, 2024 | RX | Yes | Yes | 12,263,158 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Fidelity Biopharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 7627353 | ⤷ Start Trial |
| China | 115400123 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2022247609 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
